DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0036572 | Seizures | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C1961835 | Gaucher Disease, Type 1 | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0206663 | Neuroectodermal Tumor, Primitive | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0220756 | Niemann-Pick Disease, Type C | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0038220 | Status Epilepticus | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C3887461 | Head and Neck Carcinoma | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0497327 | Dementia | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0011880 | Diabetic Ketoacidosis | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0024117 | Chronic Obstructive Airway Disease | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C4048328 | cervical cancer | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0020456 | Hyperglycemia | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0011581 | Depressive disorder | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0677886 | Epithelial ovarian cancer | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0025312 | Meningomyelocele | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0018790 | Cardiac Arrest | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C0004364 | Autoimmune Diseases | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0024141 | Lupus Erythematosus, Systemic | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C1306459 | Primary malignant neoplasm | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0036341 | Schizophrenia | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C2239176 | Liver carcinoma | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C1621958 | Glioblastoma Multiforme | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0002876 | Congenital dyserythropoietic anemia | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0027651 | Neoplasms | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0600139 | Prostate carcinoma | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0376358 | Malignant neoplasm of prostate | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024